We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Rebranding of Contrast Agent Company Creates New Markets and Growth Opportunities

By HospiMedica International staff writers
Posted on 10 Oct 2011
Agfa HealthCare (Mortsel, Belgium) announced that it is changing the name of Insight Agents, GmbH (Heidelberg, Germany) to Agfa HealthCare Imaging Agents. More...
A German company manufacturing generic contract media, Insight Agents was acquired by Agfa HealthCare in January 2010. The rebranding will support Agfa HealthCare as it extends the marketing and sales of the contrast media throughout Europe and globally.

The acquisition of Insight Agents was aimed at enhancing Agfa HealthCare’s diagnostic imaging business with a set of products that are increasingly used for diagnostic imaging procedures. The products are a logical addition to the company's successful imaging product range.

The rebranding of Insight Agents as Agfa HealthCare Imaging Agents will play a key role in extending the existing sales and marketing of the generic contrast media portfolio in Europe, as it expands its market presence globally. “Agfa HealthCare is known for in-depth knowledge of healthcare technology and clinical needs,” commented Dirk De Langhe, global business unit manager imaging agents, Agfa HealthCare. “We also have a clear goal of continuously improving our ability to deliver on-quality, on-time, and on-expectation. We will build on these strengths to maximize the growth potential of the acquisition and subsequent rebranding.”

With the increasing demand for diagnostic imaging, including in emerging markets, generic contrast media have an important role to play. “Healthcare costs are under a lot of pressure right now, but a focus on quality is still essential,” said Mr. De Langhe. “Our generic contrast media can meet both requirements.”

Agfa HealthCare Imaging Agents will continue to expand its contrast media product range as well, by developing products as existing third party patents expire. These imaging agents are not available in Canada or the United States.

Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare information technology (IT) solutions. Agfa HealthCare develops systems for capturing, managing, and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were EUR 1.18 billion.

Related Links:
Agfa HealthCare
Insight Agents



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Portable Jaundice Management Device
Nymphaea
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.